HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.870-3.950 for the period, compared to the consensus earnings per share estimate of 3.690. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $0.48 during trading on Tuesday, reaching $74.36. The stock had a trading volume of 987,588 shares, compared to its average volume of 1,138,866. The business’s 50-day moving average price is $88.03 and its 200 day moving average price is $92.07. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. HealthEquity has a 52 week low of $72.76 and a 52 week high of $116.65. The stock has a market capitalization of $6.35 billion, a PE ratio of 34.11, a P/E/G ratio of 0.92 and a beta of 0.24.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities analysts predict that HealthEquity will post 2.32 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have commented on HQY shares. KeyCorp increased their price objective on HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, January 8th. BTIG Research cut their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. Raymond James Financial set a $100.00 target price on HealthEquity in a report on Tuesday. Finally, BMO Capital Markets reissued a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $116.13.

Insider Activity

In related news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,959 shares of company stock valued at $1,344,957 in the last ninety days. 1.50% of the stock is currently owned by insiders.

Institutional Investors Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently made changes to their positions in HQY. Fiduciary Trust Co lifted its holdings in shares of HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares during the last quarter. Larson Financial Group LLC increased its position in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares in the last quarter. Merit Financial Group LLC lifted its stake in HealthEquity by 8.9% in the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock valued at $200,000 after purchasing an additional 172 shares during the last quarter. Parallel Advisors LLC boosted its position in HealthEquity by 14.3% in the fourth quarter. Parallel Advisors LLC now owns 1,387 shares of the company’s stock valued at $127,000 after buying an additional 173 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in HealthEquity by 51.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 793 shares of the company’s stock valued at $73,000 after buying an additional 271 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.